The Canada Point of Care Molecular Diagnostics Market, valued at USD 350 million in 2024, is projected to reach USD 560 ...

The system is intended for use in urgent care clinics, primary care settings, physician office laboratories, and pharmacies.

PCR is a well-established technique, and over the past decade, it has been adapted to quantify RNA and DNA quicker and more accurately. Multiplex PCR technologies have been developed to increase the ...

Company and CoSara believe that ISO certification is a critical component of the regulatory requirements for clearance of new ...

LEX, which is based at Melbourn Science Park, was founded in 2020 as a spin-out from TTP Group. The FDA application for VELO ...

Acute respiratory infections remain one of the leading causes of hospitalization in children worldwide. Pathogens may interact with one another, altering disease patterns in unpredictable ways. The ...

The COVID-19 pandemic led to a disruption of infection rates of many common respiratory diseases in children. However, the aftereffects of the pandemic, once restrictions were removed, remain unclear.

LEX Diagnostics, a leading innovator in molecular diagnostics, has received U.S. Food and Drug Administration (FDA) 510(k) ...

Global Molecular Infectious Disease Testing Market OverviewThe global molecular infectious disease testing market is ...

LEX Diagnostics, a Cambridgeshire-based innovator in molecular diagnostics, has received U.S. Food and Drug Administration (FDA) 510(k) clearance and CLIA waived status for a platform that could ...

LEX Diagnostics receives US FDA 510(k) clearance and CLIA waiver for LEX VELO system: Cambridgeshire, UK Tuesday, February 17, 2026, 17:00 Hrs [IST] LEX Diagnostics, a leading inn ...

The latent TB testing market presents opportunities through government support, tech advances in multiplex and molecular diagnostics, POC testing, telemedicine, and personalized medicine. These ...